Xiangyu Medical Co. Ltd. A
Xiangyu Medical Co.,Ltd engages in the research and development, manufacture, and marketing of rehabilitation and physiotherapy equipment in China. It provides various therapy such as smart occupational, electro, sport, rehab, cold and heat, gait training device, hydrotherapy, air compression, phototherapy, traction table, magnetic, CPM, occupational, shock wave and ultrasound, massage, treatment… Read more
Xiangyu Medical Co. Ltd. A (688626) - Total Liabilities
Latest total liabilities as of September 2025: CN¥1.23 Billion CNY
Based on the latest financial reports, Xiangyu Medical Co. Ltd. A (688626) has total liabilities worth CN¥1.23 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Xiangyu Medical Co. Ltd. A - Total Liabilities Trend (2017–2024)
This chart illustrates how Xiangyu Medical Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Xiangyu Medical Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Xiangyu Medical Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Saul Centers Inc
NYSE:BFS
|
USA | $1.68 Billion |
|
EverQuote Inc Class A
NASDAQ:EVER
|
USA | $81.12 Million |
|
Sinopec Kantons Holdings Limited
F:SAK
|
Germany | €760.53 Million |
|
Probe Gold Inc.
TO:PRB
|
Canada | CA$12.58 Million |
|
Anpec Electronics
TWO:6138
|
Taiwan | NT$1.74 Billion |
|
Tangel Publishing
SHE:300148
|
China | CN¥316.83 Million |
|
Bengang Steel Plates Co Ltd
SHE:000761
|
China | CN¥36.45 Billion |
|
Mochida Pharmaceutical Co. Ltd
F:MFY
|
Germany | €29.43 Billion |
Liability Composition Analysis (2017–2024)
This chart breaks down Xiangyu Medical Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.61 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Xiangyu Medical Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Xiangyu Medical Co. Ltd. A (2017–2024)
The table below shows the annual total liabilities of Xiangyu Medical Co. Ltd. A from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥873.10 Million | +80.13% |
| 2023-12-31 | CN¥484.69 Million | +13.19% |
| 2022-12-31 | CN¥428.22 Million | +80.71% |
| 2021-12-31 | CN¥236.97 Million | -0.54% |
| 2020-12-31 | CN¥238.25 Million | +34.76% |
| 2019-12-31 | CN¥176.79 Million | +20.53% |
| 2018-12-31 | CN¥146.68 Million | -51.52% |
| 2017-12-31 | CN¥302.59 Million | -- |